Company Overview of North American Vaccine
As of June 2000, North American Vaccine, Inc. was acquired by Baxter International Inc. North American Vaccine, Inc., prior to the acquisition, was engaged in the research, development, manufacture, and sale of vaccines for the prevention of infectious diseases. The company had three licensed products that contained its acellular pertussis vaccine, including Certiva®, its combined diphtheria, tetanus, and acellular pertussis vaccine for infants and children, as well as 12 other products in various stages of development to prevent meningococcal, streptococcal, pneumococcal, E. coli, and HAEMOPHILUS INFLUENZAE type b infections.
10150 Old Columbia Road
Columbia, MD 21046
Key Executives for North American Vaccine
North American Vaccine does not have any Key Executives recorded.
Similar Private Companies By Industry
|Curative Biosciences, Inc.||United States|
|Girindus America Inc.||United States|
|Arteriocyte, Inc.||United States|
|Applied Molecular Evolution, Inc.||United States|
|TELA Bio, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact North American Vaccine, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.